GlassScriptPhysician profile
June Yin
NPI 1154353332
$9,313.27
in general payments reported to CMS, 2019-2025
47 companies · $1,533 in 2025
The $1,533 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,324 · 2020: $924 · 2021: $1,541 · 2022: $1,437 · 2023: $1,453 · 2024: $1,101 · 2025: $1,533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,479 · Travel and Lodging: $608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,479.39 |
| Travel and Lodging | $607.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $1,666.49 | 2020-2025 | Ingrezza, Ongentys |
| Teva Pharmaceuticals USA, INC. | $1,001.73 | 2019-2024 | Austedo Xr, Uzedy, Austedo |
| Abbvie INC. | $767.43 | 2019-2025 | Qulipta, Ubrelvy |
| Ucb, INC. | $745.81 | 2019-2023 | Nayzilam |
| Intuitive Surgical, INC. | $607.97 | 2025 | |
| Genzyme Corporation | $514.23 | 2019-2022 | |
| Mdd US Operations, LLC | $299.28 | 2023-2024 | Gocovri, Gocovri |
| Allergan, INC. | $291.67 | 2020-2021 | |
| Lundbeck LLC | $274.71 | 2024-2025 | Rexulti, Vyepti |
| Adamas Pharmaceuticals, INC. | $256.79 | 2020-2021 | |
| Gilead Sciences, INC. | $250.00 | 2019 | |
| Ibsa Pharma INC. | $164.07 | 2021-2024 | Licart |
| Novartis Pharmaceuticals Corporation | $146.39 | 2019 | |
| Tanabe Pharma America, INC. | $142.89 | 2022-2024 | |
| Acadia Pharmaceuticals INC | $140.11 | 2020-2025 | Nuplazid |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw June Yin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.